EP1970054A3 - Clopidogrel-Tabletten - Google Patents

Clopidogrel-Tabletten Download PDF

Info

Publication number
EP1970054A3
EP1970054A3 EP08152781A EP08152781A EP1970054A3 EP 1970054 A3 EP1970054 A3 EP 1970054A3 EP 08152781 A EP08152781 A EP 08152781A EP 08152781 A EP08152781 A EP 08152781A EP 1970054 A3 EP1970054 A3 EP 1970054A3
Authority
EP
European Patent Office
Prior art keywords
tablets
clopidogrel
clopidogrel tablets
punch
sticking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08152781A
Other languages
English (en)
French (fr)
Other versions
EP1970054A2 (de
Inventor
Sachin Gahoi
Raveendra Pai
Ajay Kumar Singla
Khalid Rafi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of EP1970054A2 publication Critical patent/EP1970054A2/de
Publication of EP1970054A3 publication Critical patent/EP1970054A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP08152781A 2007-03-14 2008-03-14 Clopidogrel-Tabletten Withdrawn EP1970054A3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN548DE2007 2007-03-14

Publications (2)

Publication Number Publication Date
EP1970054A2 EP1970054A2 (de) 2008-09-17
EP1970054A3 true EP1970054A3 (de) 2009-06-03

Family

ID=39472477

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08152781A Withdrawn EP1970054A3 (de) 2007-03-14 2008-03-14 Clopidogrel-Tabletten

Country Status (1)

Country Link
EP (1) EP1970054A3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101766573B (zh) 2010-02-05 2013-02-13 上海安必生制药技术有限公司 硫酸氢氯吡格雷固体制剂的制备工艺
CN105748419B (zh) * 2015-07-17 2018-09-14 深圳信立泰药业股份有限公司 一种含有球形硫酸氢氯吡格雷i晶型的药物组合物及其制备方法
CN105106165A (zh) * 2015-08-19 2015-12-02 海南科进生物制药有限公司 一种硫酸氢氯吡咯雷片及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1310245A1 (de) * 2001-11-09 2003-05-14 SHERMAN, Bernard Charles Clopidogrelbisulfathaltige Tablettenzubereitung
GB2393181A (en) * 2002-09-19 2004-03-24 Cipla Ltd Amorphous clopidogrel
WO2005048992A1 (en) * 2003-11-03 2005-06-02 Sandoz Ag Process for preparing clopidogrel compositions
WO2007025764A2 (de) * 2005-09-01 2007-03-08 Helm Ag Pharmazeutische formulierung für salze monobasischer säuren mit clopidogrel

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5576328A (en) 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
HUP0200438A3 (en) 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
AU2003241149A1 (en) 2003-05-05 2004-11-26 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate composition
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EA008972B1 (ru) 2004-01-13 2007-10-26 Зентива А.С. Новые кристаллические формы гидробромида клопидогреля и способы их получения
WO2005070464A2 (en) 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
WO2005117866A1 (en) 2004-06-01 2005-12-15 Ivax Pharmaceuticals S.R.O. Amorphous clopidogrel hydrochloride and its antithrombotic use
EP1704152A2 (de) 2004-09-21 2006-09-27 Teva Pharmaceutical Industries Ltd Kristallines clopidogrelhydrobromid und verfahren zu dessen herstellung
KR20070009851A (ko) 2005-07-14 2007-01-19 씨제이 주식회사 클로피도그렐 황산수소염 함유 약학 조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1310245A1 (de) * 2001-11-09 2003-05-14 SHERMAN, Bernard Charles Clopidogrelbisulfathaltige Tablettenzubereitung
GB2393181A (en) * 2002-09-19 2004-03-24 Cipla Ltd Amorphous clopidogrel
WO2005048992A1 (en) * 2003-11-03 2005-06-02 Sandoz Ag Process for preparing clopidogrel compositions
WO2007025764A2 (de) * 2005-09-01 2007-03-08 Helm Ag Pharmazeutische formulierung für salze monobasischer säuren mit clopidogrel

Also Published As

Publication number Publication date
EP1970054A2 (de) 2008-09-17

Similar Documents

Publication Publication Date Title
ZA200902611B (en) Coated steel strips, methods of making the same, methods of using the same, stamping blanks prepared from the same, stamped products prepared from the same, and articles of manufacture which contain such a stamped product
EP2058345A4 (de) Verfahren zur herstellung eines blockcopolymers und blockcopolymer oder hydrierungsprodukt davon
WO2007106738A3 (en) Acrylated hyaluronic acid
WO2005112897A3 (en) Immediate release pharmaceutical tablets with height greater than width
WO2007144424A3 (en) Processes for production of a starch hydrolysate
WO2009068214A3 (de) Heteroaryl-substituierte piperidine
EP1848791A4 (de) Verfahren zur herstellung von gärungsprodukten
EP2368544A4 (de) Rasch im mund zerfallende tablette und verfahren zu ihrer herstellung
PL2427325T3 (pl) Prasa rotacyjna, zwłaszcza do wytwarzania tabletek
EP1879486A4 (de) Automatische herstellungsvorgänge und zugeordnete systeme, einschliesslich automatischer brotherstellungsverfahren
TW200806221A (en) Method of relating different products by a common feature
EP2514535A4 (de) Lochpresse
CA2863376A1 (en) Gastroretentive tablets
EP1958619A4 (de) Verfahren zur herstellung einer tablette durch direkte hochgeschwindigkeits-kompression
EP1970054A3 (de) Clopidogrel-Tabletten
IL195886A0 (en) Pharmaceutical tablets with diffractive microstructure and compression dies for producing such tablets
WO2008024406A3 (en) Tabletting press
WO2007141282A3 (en) Process for making multiparticulates using a roller compactor
ZA200706067B (en) Production process for NSAID-containing lozenges, their compositions, their medicinal use
WO2011003603A3 (de) Zusammensetzung für die tablettenherstellung und verfahren zu deren herstellung
EP2095895A4 (de) Aluminiumdruckgussprodukt und verfahren zu dessen herstellung
IL202244A0 (en) Die press assembly for powder pressing
WO2008099283A3 (en) Method and apparatus for producing a centred compression coated tablet
WO2006072920A3 (en) Tablets of stevia extract and process for their preparation
GB2446788B (en) A punch and die arrangement for manufacturing number plate components

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/44 20060101ALN20080610BHEP

Ipc: A61K 47/14 20060101ALI20090424BHEP

Ipc: A61K 31/4365 20060101ALI20090424BHEP

Ipc: A61K 9/20 20060101AFI20080610BHEP

17P Request for examination filed

Effective date: 20091203

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20100201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110401